| Title |
Efficacy and completion rates of rifapentine and isoniazid (3HP) compared to other treatment regimens for latent tuberculosis infection: a systematic review with network meta-analyses
|
|---|---|
| Published in |
BMC Infectious Diseases, April 2017
|
| DOI | 10.1186/s12879-017-2377-x |
| Pubmed ID | |
| Authors |
Christopher Pease, Brian Hutton, Fatemeh Yazdi, Dianna Wolfe, Candyce Hamel, Pauline Quach, Becky Skidmore, David Moher, Gonzalo G. Alvarez |
X Demographics
The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Switzerland | 2 | 13% |
| Canada | 2 | 13% |
| India | 2 | 13% |
| Italy | 1 | 7% |
| South Africa | 1 | 7% |
| United States | 1 | 7% |
| Venezuela, Bolivarian Republic of | 1 | 7% |
| Australia | 1 | 7% |
| Unknown | 4 | 27% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 6 | 40% |
| Scientists | 5 | 33% |
| Practitioners (doctors, other healthcare professionals) | 3 | 20% |
| Science communicators (journalists, bloggers, editors) | 1 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 140 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 140 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 29 | 21% |
| Researcher | 14 | 10% |
| Other | 10 | 7% |
| Student > Ph. D. Student | 10 | 7% |
| Student > Bachelor | 7 | 5% |
| Other | 23 | 16% |
| Unknown | 47 | 34% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 54 | 39% |
| Nursing and Health Professions | 14 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 3% |
| Immunology and Microbiology | 4 | 3% |
| Biochemistry, Genetics and Molecular Biology | 3 | 2% |
| Other | 8 | 6% |
| Unknown | 53 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 107. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 April 2024.
All research outputs
#402,239
of 25,757,133 outputs
Outputs from BMC Infectious Diseases
#106
of 8,698 outputs
Outputs of similar age
#8,395
of 325,647 outputs
Outputs of similar age from BMC Infectious Diseases
#2
of 173 outputs
Altmetric has tracked 25,757,133 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,698 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 325,647 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 173 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.